Avenue Therapeutics (ATXI) Research & Development (2016 - 2026)
Avenue Therapeutics' Research & Development was $247,000 in Q2 2026, up 28.6% from $192,000 a year earlier and up 23.5% from the prior quarter.
Powered by 
Analysis
Avenue Therapeutics (ATXI) Research & Development (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Avenue Therapeutics' Research & Development was $881,000 through Jun 30, 2026, down 74.8% year-over-year; for FY2025, it was $1.04 million, down 84.4% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -18.4% (FY2020 to FY2025).
- In earlier years, Research & Development was $6.65 million in FY2024 (+8.4%), $6.13 million in FY2023 (+127.2%), $2.7 million in FY2022 (+115.2%) and $1.25 million in FY2021 (-56.2%).
- Quarterly Research & Development has moved between $151,000 (Q2 2022) and $3.03 million (Q2 2023) over five years.
- Compared with a year earlier, Research & Development was higher in two of the last eight quarters, with an average decline of 28.0%.
- The best year-over-year quarter for Research & Development over five years was Q1 2022 (growth of 600.8%); the worst was Q3 2025 (a decline of 92.4%).
- Per Business Quant data, ATXI's Research & Development in the three quarters before Q2 2026 was $200,000 (Q1 2026), $257,000 (Q4 2025) and $177,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Avenue Therapeutics | 1.32 Mn | -9.61 Mn | - | 247,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 247,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 257,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Jun 30, 2025 | 192,000.00 |
| Mar 31, 2025 | 411,000.00 |
| Dec 31, 2024 | 565,000.00 |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 2.39 Mn |
| Dec 31, 2023 | 982,000.00 |
| Sep 30, 2023 | 907,000.00 |
| Jun 30, 2023 | 3.03 Mn |
| Mar 31, 2023 | 1.22 Mn |
| Dec 31, 2022 | 545,000.00 |
| Sep 30, 2022 | 194,000.00 |
| Jun 30, 2022 | 151,000.00 |
| Mar 31, 2022 | 1.81 Mn |
| Dec 31, 2021 | 390,000.00 |
| Sep 30, 2021 | 278,000.00 |
API Access
Avenue Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ATXI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ATXI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ATXI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();